Inhalon Biopharma
Manufacturing · North Carolina, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2 discovery At Ste 220, Morrisville, Nor...Phone Number
(650) 439-0110Website
www.inhalon.comRevenue
$5.5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Inhalon Biopharma
Inhalon Biopharma is a clinical-stage biotechnology company focused on developing an innovative inhaled drug platform for treating acute respiratory infections, including RSV, hMPV, influenza, and SARS-CoV-2. The company aims to enhance treatment effectiveness and convenience for patients through its proprietary inhaled antibody treatments. Inhalon is committed to establishing a simplified test-to-treat model as a new standard in respiratory care. Their target clients include patients suffering from various respiratory infections who seek effective and accessible treatment options.Explore more
Inhalon Biopharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Inhalon Biopharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Inhalon Biopharma had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Inhalon Biopharma recently announced quarterly report
Inhalon Biopharma, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Inhalon Biopharma has new funding data
Congratulate Masked Content for being promoted to Masked Content at Inhalon Biopharma
Check if Inhalon Biopharma has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Inhalon Biopharma launches new products
Check out if Inhalon Biopharma is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Inhalon Biopharma
Find 3 more new buyers
Compare Similar Companies to Inhalon Biopharma
Compare insights from companies similar to Inhalon Biopharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Inhalon Biopharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Inhalon Biopharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Inhalon Biopharma.
Inhalon Biopharma Tech Stack
A closer look at the technologies used by Inhalon Biopharma
Most Recent Scoops
Hiring Plans
Inhalon Biopharma has more open roles in Operations than it has had at any time in the past 12 months.
Hiring Plans
Funding
Project
Spending/Investment, Funding
Funding
Project
Spending/Investment, Funding
Person-Based
Person-Based
Inhalon Biopharma News & Media
Inhalon Biopharma Announces Positive Results from Study Demonstrating Superior Safety and Efficacy of its Inhaled Antibody Platform Over Systemic Dosing
DURHAM, N.C.--(BUSINESS WIRE)--Inhalon Biopharma shares positive results from study demonstrating superior safety and efficacy of its inhaled antibody platform over systemic dosing.Inhalon Biopharma Announces Two Publications Advancing its Inhaled Antibody Treatment Platform for Acute Respiratory Infections
DURHAM, N.C.--(BUSINESS WIRE)--Inhalon Biopharma announces data on its inhaled antibody treatment platform and plans to advance RSV and SARS-CoV-2 candidates into the clinic.Inhalon Biopharma Secures U.S. Army Medical Research and Development Command Award to Support Development of Inhaled Therapeutics for Treatment of COVID-19
DURHAM, N.C.--(BUSINESS WIRE)--Inhalon Biopharma secured a U.S. Army Medical Research and Development Command Award to support development of inhaled therapeutics for COVID-19.Inhalon Biopharma Expands Therapeutic Horizons with Licensing of hMPV Antibodies from the University of Georgia
DURHAM, N.C.--(BUSINESS WIRE)--Inhalon Biopharma licensed hMPV antibodies from the University of Georgia as it builds its pipeline of potential treatments for respiratory infections
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Inhalon Biopharma
Sign Up For FreeTo access detailed company insights
Inhalon Biopharma is a clinical-stage biotechnology company focused on developing an innovative inhaled drug platform for treating acute respiratory infections, including RSV, hMPV, influenza, and SARS-CoV-2. The company aims to enhance treatment effectiveness and convenience for patients through its proprietary inhaled antibody treatments. Inhalon... Read More
